PMEF
EIGR

Point72 Middle East FZE’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Point72 Middle East FZE’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-105
Closed -$2.22K – 1512
2023
Q2 		$2.22K Buy
+105
New +$2.22K ﹤0.01% 914